Anti-parasite therapy drives changes in human visceral leishmaniasis-associated inflammatory balance
Abstract Visceral leishmaniasis (VL) remains a major public health problem worldwide. Cytokine balance is thought to play a critical role in the development of this disease. Here, we perform a prospective exploratory study addressing whether simultaneous assessment of circulating levels of different...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/799be9b2280e4569a562fe387b5f87b2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:799be9b2280e4569a562fe387b5f87b2 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:799be9b2280e4569a562fe387b5f87b22021-12-02T15:18:52ZAnti-parasite therapy drives changes in human visceral leishmaniasis-associated inflammatory balance10.1038/s41598-017-04595-82045-2322https://doaj.org/article/799be9b2280e4569a562fe387b5f87b22017-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-04595-8https://doaj.org/toc/2045-2322Abstract Visceral leishmaniasis (VL) remains a major public health problem worldwide. Cytokine balance is thought to play a critical role in the development of this disease. Here, we perform a prospective exploratory study addressing whether simultaneous assessment of circulating levels of different lipid mediators and cytokines could highlight specific pathways involved with VL pathogenesis. VL patients displayed substantial increases in serum levels of Prostaglandin F2α (PGF2α), Leukotriene B4 (LTB4), Resolvin D1 (RvD1), IL-1β, IL-6, IL-8, IL-10, IL-12p70 and TNF-α compared with uninfected endemic control group, while exhibiting decreased levels of TGF-β1. Hierarchical cluster analysis of the prospective changes in the expression level of theses parameters upon anti-Leishmania treatment initiation revealed that the inflammatory profile observed in active disease gradually changed over time and was generally reversed at day 30 of therapy. Furthermore, not only the individual concentrations of most of the inflammatory biomarkers changed upon treatment, but the correlations between those and several biochemical parameters used to characterize VL disease activity were also modified over time. These results demonstrate that an inflammatory imbalance hallmarks active VL disease and open perspective for manipulation of these pathways in future studies examining a potential host-directed therapy against VL.Théo Araújo-SantosBruno B. AndradeLeonardo Gil-SantanaNívea F. LuzPriscila L. dos SantosFabrícia A. de OliveiraMeirielly Lima AlmeidaRoseane Nunes de Santana CamposPatrícia T. BozzaRoque P. AlmeidaValeria M. BorgesNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-8 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Théo Araújo-Santos Bruno B. Andrade Leonardo Gil-Santana Nívea F. Luz Priscila L. dos Santos Fabrícia A. de Oliveira Meirielly Lima Almeida Roseane Nunes de Santana Campos Patrícia T. Bozza Roque P. Almeida Valeria M. Borges Anti-parasite therapy drives changes in human visceral leishmaniasis-associated inflammatory balance |
description |
Abstract Visceral leishmaniasis (VL) remains a major public health problem worldwide. Cytokine balance is thought to play a critical role in the development of this disease. Here, we perform a prospective exploratory study addressing whether simultaneous assessment of circulating levels of different lipid mediators and cytokines could highlight specific pathways involved with VL pathogenesis. VL patients displayed substantial increases in serum levels of Prostaglandin F2α (PGF2α), Leukotriene B4 (LTB4), Resolvin D1 (RvD1), IL-1β, IL-6, IL-8, IL-10, IL-12p70 and TNF-α compared with uninfected endemic control group, while exhibiting decreased levels of TGF-β1. Hierarchical cluster analysis of the prospective changes in the expression level of theses parameters upon anti-Leishmania treatment initiation revealed that the inflammatory profile observed in active disease gradually changed over time and was generally reversed at day 30 of therapy. Furthermore, not only the individual concentrations of most of the inflammatory biomarkers changed upon treatment, but the correlations between those and several biochemical parameters used to characterize VL disease activity were also modified over time. These results demonstrate that an inflammatory imbalance hallmarks active VL disease and open perspective for manipulation of these pathways in future studies examining a potential host-directed therapy against VL. |
format |
article |
author |
Théo Araújo-Santos Bruno B. Andrade Leonardo Gil-Santana Nívea F. Luz Priscila L. dos Santos Fabrícia A. de Oliveira Meirielly Lima Almeida Roseane Nunes de Santana Campos Patrícia T. Bozza Roque P. Almeida Valeria M. Borges |
author_facet |
Théo Araújo-Santos Bruno B. Andrade Leonardo Gil-Santana Nívea F. Luz Priscila L. dos Santos Fabrícia A. de Oliveira Meirielly Lima Almeida Roseane Nunes de Santana Campos Patrícia T. Bozza Roque P. Almeida Valeria M. Borges |
author_sort |
Théo Araújo-Santos |
title |
Anti-parasite therapy drives changes in human visceral leishmaniasis-associated inflammatory balance |
title_short |
Anti-parasite therapy drives changes in human visceral leishmaniasis-associated inflammatory balance |
title_full |
Anti-parasite therapy drives changes in human visceral leishmaniasis-associated inflammatory balance |
title_fullStr |
Anti-parasite therapy drives changes in human visceral leishmaniasis-associated inflammatory balance |
title_full_unstemmed |
Anti-parasite therapy drives changes in human visceral leishmaniasis-associated inflammatory balance |
title_sort |
anti-parasite therapy drives changes in human visceral leishmaniasis-associated inflammatory balance |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/799be9b2280e4569a562fe387b5f87b2 |
work_keys_str_mv |
AT theoaraujosantos antiparasitetherapydriveschangesinhumanvisceralleishmaniasisassociatedinflammatorybalance AT brunobandrade antiparasitetherapydriveschangesinhumanvisceralleishmaniasisassociatedinflammatorybalance AT leonardogilsantana antiparasitetherapydriveschangesinhumanvisceralleishmaniasisassociatedinflammatorybalance AT niveafluz antiparasitetherapydriveschangesinhumanvisceralleishmaniasisassociatedinflammatorybalance AT priscilaldossantos antiparasitetherapydriveschangesinhumanvisceralleishmaniasisassociatedinflammatorybalance AT fabriciaadeoliveira antiparasitetherapydriveschangesinhumanvisceralleishmaniasisassociatedinflammatorybalance AT meiriellylimaalmeida antiparasitetherapydriveschangesinhumanvisceralleishmaniasisassociatedinflammatorybalance AT roseanenunesdesantanacampos antiparasitetherapydriveschangesinhumanvisceralleishmaniasisassociatedinflammatorybalance AT patriciatbozza antiparasitetherapydriveschangesinhumanvisceralleishmaniasisassociatedinflammatorybalance AT roquepalmeida antiparasitetherapydriveschangesinhumanvisceralleishmaniasisassociatedinflammatorybalance AT valeriamborges antiparasitetherapydriveschangesinhumanvisceralleishmaniasisassociatedinflammatorybalance |
_version_ |
1718387453898784768 |